Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 62,137 | 54,301 | 52,078 | 135,586 | 106,095 |
| Marketable Securities | 278,488 | 334,648 | 363,974 | 155,444 | 208,393 |
| Receivables | 34,192 | 26,081 | 33,034 | 26,122 | 17,825 |
| Inventories | 28,651 | 25,753 | 22,107 | 18,872 | 19,316 |
| TOTAL | $430,090 | $466,916 | $494,802 | $360,680 | $369,288 |
| Non-Current Assets | |||||
| PPE Net | 1,065 | 1,104 | 237 | 297 | 462 |
| Intangibles | 5,106 | 5,319 | 5,533 | 5,747 | 5,960 |
| Other Non-Current Assets | 6,055 | 6,857 | 6,302 | 6,009 | 10,975 |
| TOTAL | $12,226 | $13,280 | $12,072 | $12,053 | $17,397 |
| Total Assets | $442,316 | $480,196 | $506,874 | $372,733 | $386,685 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,299 | 13,947 | 13,631 | 15,982 | 11,912 |
| Accrued Expenses | 80,045 | 83,855 | 84,456 | 69,185 | 59,314 |
| Other current liabilities | N/A | N/A | 0 | 40,000 | 38,783 |
| TOTAL | $103,198 | $105,942 | $104,267 | $129,455 | $111,823 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 10,178 | 7,490 | 5,556 | 3,778 | 1,590 |
| Other Non-Current Liabilities | 3,163 | 3,342 | 3,515 | 3,681 | 3,839 |
| TOTAL | $101,502 | $104,228 | $106,924 | $109,695 | $111,773 |
| Total Liabilities | $204,700 | $210,170 | $211,191 | $239,150 | $223,596 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 68,533 | 68,285 | 66,736 | 66,420 | 63,621 |
| Common Shares | 69 | 67 | 67 | 64 | 62 |
| Retained earnings | -1,407,516 | -1,351,877 | -1,304,372 | -1,251,468 | -1,204,836 |
| Other shareholders' equity | 115,154 | 130,161 | 145,940 | 143,243 | 144,091 |
| TOTAL | $237,616 | $270,026 | $295,683 | $133,583 | $163,089 |
| Total Liabilities And Equity | $442,316 | $480,196 | $506,874 | $372,733 | $386,685 |